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INTRODUCTION
There is an increasing demand for the production of biodegradable plastics from renewable feedstocks due to both dwindling fossil fuel supplies and environmental concerns over the accumulation of petroleum-based non-recyclable plastic waste. [1] [2] [3] This has led to the development biodegradable polymeric materials, including elastomers, plastics, hydrogels, flexible electronics, resins, engineering polymers and composites. 4 Cyclic esters (lactones) have been widely used in the synthesis of biodegradable polymers, such as poly-ε-caprolactone (PCL) 5 and polylactide (PLA) and related copolymers [6] [7] [8] [9] [10] , which are employed in a number of biomedical and pharmaceutical applications such as in drug delivery and tissue engineering [11] [12] [13] [14] and constitute the major component of many types of polyurethane biopolymers. 15 Other bio-derived monomers of commercial interest are monoterpenoids, which generate polymers such as polymenthide (PM), polydihydrocarvide (PDC) and polycarvomenthide (PCM) and related Scheme 1. Semisynthetic polymer production using lactone monomers.
Semisynthetic polymer production via BVMO-catalyzed lactone production coupled with ROP oxidation using Mg(BHT) 2 (THF) 2 and benzyl alcohol. 30 Ring-opening polymerization (ROP) reactions of lactone monomers are a common strategy to access polymers such as PM and PDC and similar polymers such as PCL and β-pinene. 7, 15, 19, 20, 31 The use of metal catalysts for the polymerization of ε-caprolactone, menthide, dihydrocarvide and carvomenthide is well established. [32] [33] [34] Alternatively, enzymatic approaches employing lipase enzymes have been reported for low molecular weight polylactide production. 35, 36 This report describes an alternative route to lactone-based biopolymers by employing a biocatalytic lactone production step using BVMOs with ROP using mild metal-organic catalysts. This approach utilizes bio-derived monoterpenoid starting materials to generate lactone monomers using the BVMO enzymes cyclopentadecanone monooxygenase (CPDMO) from Pseudomonas sp. HI-70 37 and cyclohexanone monooxygenase from Rhodococcus sp. Phi1 (CHMO Phi1 ). 38 To enable the production of the 'normal' lactone from (+)-dihydrocarvone, we performed site-directed mutagenesis of CHMO Phi1 , and determined the crystal structures of the wild type (WT) and variant enzymes. A combination of structural analyses, molecular dynamics and computational mechanistic studies gave insights into the mechanisms that drive the formation of abnormal and normal lactone from (+)-dihydrocarvone. Finally, ROP reactions using a milder metal-organic catalyst than the ones utilized in the current polymerization process enabled the generation of polymers that were characterized and analyzed. Our method provides an alternative approach to access lactone monomers converting low-value renewable resources into value-added polymers.
MATERIALS AND METHODS
CHMO gene syntheses and mutagenesis. The genes encoding CPDMO from Pseudomonas sp.
HI-70 (UniProtKB: T2HVF7) and CHMO Phi1 from Rhodococcus sp. Phi1 (UniProtKB: Q84H73) were synthesized by GenScript (USA), employing codon optimization for increased E. coli expression. CPDMO was sub cloned into pET15b, incorporating an N-terminal His 6 -tag and CHMO Phi1 into pET21b with a C-terminal His 6 -tag. The CHMO Phi1 triple variant F249A, F280A, F435A (variant thereafter) was generated by QuikChange site-directed mutagenesis (Agilent) according to the manufacturer's protocols. Primer sequences used for the construction of the variant are shown in Table S1 , Supporting Information). CPDMO and both CHMO Phi1 (WT and variant) constructs were transformed into E. coli strains BL21(DE3) and C41(DE3), respectively, for protein overexpression.
The BVMOs were purified from the cell pellets using Ni-NTA affinity chromatography according to the manufacturers protocols (Qiagen), followed by gel filtration for crystallography studies.
Protein concentrations were determined by either UV-Visible spectroscopy (ε 450nm = 11,300 M -1 cm -1 for flavins) or the Bio-Rad protein assay kit. Typical cell expression yields, purities and UV/Vis spectrum of each BVMO can be found in Table S2 and Figures S1-S2, respectively.
Self-sufficient biocatalyst production. Each BVMO was fused to the C-terminus of the cofactor regenerating enzyme (CRE) phosphite dehydrogenase from Pseudomonas stutzeri (PTDH; thermostable variant 18-ptxD) [39] [40] [41] via a six amino acid linker (SRSAAG) as described previously. 41, 42 Constructs were generated in pET15b, which positioned the His 6 -tag at the N-terminus of PTDH.
Each CRE-BVMO was transformed into E. coli strain BL21(DE3) for protein overexpression (see
Supporting Information for details).
Analytical scale biotransformations. Biotransformations (1 mL) with either purified BVMOs (2 µM) or cell-free extracts, CFEs (50 µL) were performed in buffer (50 mM Tris pH 7.0) containing substrate (5 mM unless otherwise stated) and a cofactor recycling system (15 µM NADP + , 15 mM glucose and 10 U glucose dehydrogenase (GDH) from Pseudomonas sp.). Reactions with CRE-BVMOs contained sodium phosphite (100 mM) in the place of the cofactor recycling system.
Reactions were agitated (140 rpm) for 12 h at 28 °C, and terminated by extraction with ethyl acetate (1 mL) containing an internal standard (0.1% sec-butyl-benzene). The extracts were dried using anhydrous magnesium sulfate, and analysed by GC/MS (see Supporting Information for further details). Quantitative analysis was carried out by a comparison of product peak areas to standards of known concentrations.
Preparative scale reactions for lactone generation. Biotransformations (500 mL) were carried out with CRE-BVMOs (CFEs; 25 mL) in buffer (50 mM Tris pH 7.0) containing substrate (5 mM) and sodium phosphite (100 mM). The reactions were agitated (140 rpm) at 28 °C for 12 h followed by multiple ethyl acetate extractions (20 x 25 mL fractions). The pooled extracts were dried using anhydrous magnesium sulfate and concentrated in vacuo to give the crude lactone monomers as pale yellow oils. The crude samples were further purified by flash column chromatography (hexane:ethyl acetate, 9:1) to afford the pure lactone monomers as clear oils (46-14. 5% isolated yield of high purity product > 99.0%). The identity and purity of the lactone monomers produced were assessed by GC/MS and NMR ( 1 H NMR and 13 C NMR) analysis (Figures S3-S14).
Lactone polymerization. The ROP of lactone monomers was performed using the metal-organic catalyst magnesium 2,6-di-tert-butyl-4-methylphenoxide [Mg(BHT) 2 (THF) 2 ] at 80 °C as described previously, but conducting the reaction in 2 mL. 30 Due to the oxygen and moisture sensitivity of the reaction, lactones were lyophilised, followed by an additional drying step over activated silica for 48 h. ROP of the commercially available ε-caprolactone was also performed to produce PCL.
Polymerization reactions were performed anaerobically, keeping a ratio of 50:1:1 for the monomers:catalyst:initiator (Table S3 ).The polymerization process was carried out in an oxygenand moisture free environment (both < 0.5 ppm). Polymer PM was purified as reported, 30 while PCL was purified by precipitation into hexane followed by a drying step. Purification of PDC was performed in a hexane/ethyl acetate (9:1) mixture, recovered from the immiscible layer and dried.
Gel permeation chromatography (GPC) and 1 H NMR spectroscopy was used to detect polymer formation.
Protein crystallization and structure solution. Both CHMO Phi1 WT and variant proteins (8-10 mg/mL) were subjected to crystallization as apoproteins and in the presence of NADP + (2 mM). X-ray data were collected at Diamond Light Source beamlines I03 and I04-1. Data were processed using xia2 43 implementing XDS 44 and XSCALE. The WT and the variant structures of CHMO Phi1 were solved by molecular replacement using CHMO closed structure (PDB 3GWD) from Rhodococcus sp. HI-31 as the search model in Phaser. 45 The models were built using the AutoBuild 46 wizard in Phenix. 47 The models were completed using iterative rounds of model building using Coot 48 and refinement using phenix.refine. 49 The structures were analyzed using PDB_REDO 50 server and validated using Molprobity. 51 The X-ray data collection and refinement statistics are provided in Table 1 . The atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 6ER9 and 6ERA. Computational modeling. Molecular dynamics simulations were performed on WT and variant CHMO Phi1 in the presence of FAD and NADPH, and also in the presence of the reaction intermediate. Details of the simulations performed are described in the Supporting Information document. Mechanistic studies used "cluster models" 52, 53 and density functional theory (mPW91 + modified B95 (PWB6K) functional) to identify the key structural elements controlling the reactivity and selectivity of these biocatalysts. Details of these calculations and additional calculated data are summarized in the Supporting Information.
RESULTS AND DISCUSSION
BVMO selection and production. Previous studies showed that CPDMO oxidizes (-)-menthone to produce menthide, 37 and variant CHMOs from Arthrobacter sp. BP2 (CHMO Ar ) and Acinetobacter calcoaceticus (CHMO Ac ) generate dihydrocarvide (the normal lactone) from (+)-dihydrocarvone. 54 A screen of in house BVMOs showed that CHMO Ar and CHMO Ac expressed poorly (results not shown), while CHMO Phi1 was highly expressed and could oxidize (2R,5R)-(+)-dihydrocarvone isomer (as shown in this study). Therefore CPDMO and CHMO Phi1 were chosen for further study, and were expressed in E. coli, purified and assessed for flavin content (UV/Vis spectroscopy; Figures S1-S2; Table S2 ).
Given that BVMOs are NADPH-dependent, a cofactor recycling system is required to minimize the prohibitive costs of nicotinamide cofactor addition. 55 Prior studies with six BVMOs showed that the fusion of the C-terminus of a thermostable variant of phosphite dehydrogenase from Pseudomonas stutzeri (18-ptxD PTDH) 40 to the N-terminus of the monooxygenase via a six amino acid linker (SRSAAG) generated self-sufficient enzymes (CRE-BVMO). Cofactor regeneration during biotransformations was achieved via the action of PTDH with sodium phosphite. 41, 42 We used this strategy to generate CRE-CPDMO and CRE-CHMO Phi1 (WT and variant), all were expressed in E. coli, purified and assessed for flavin content (UV/Vis spectroscopy; Figures S1-S2; Table S2 ). This enabled comparative biotransformations to be performed in the presence of phosphite/NADP + (CRE-BVMO) or an exogenously added cofactor recycling system (glucose/GDH/NADP + ; BVMO).
Biotransformations of CPDMO.
Biotransformations (1 mL) of purified CPDMO with (-)menthone (5 mM) showed a near complete conversion to menthide, with product identification later confirmed by GC/MS, 1 H and 13 C NMR ( Figure S3 -S4 and S11, respectively). Similarly, reactions with CFEs of CPDMO or CRE-CPDMO yielded 93.5% menthide, with a minor (6.5%) secondary peak detected ( Figure S5 ). Subsequent analysis showed this minor product had identical mass fragmentation patterns to menthide, suggesting it may be a different isomer ( Figure S6 ).
To assess the scale-up potential of these reactions, reactions with CRE-CPDMO extracts were performed with variable (-)-menthone concentrations (5-50 mM) . Analytical scale reactions with substrate concentrations above 10 mM led to a significant decrease in product yield ( Table 2) .
Larger-scale reactions were performed with CRE-CPDMO extracts (500 mL), resulting in lower menthide yields of 73% and the detection of the substrate isomer isomenthone ( Figure S7 ). The generation of isomenthone with CRE-CPDMO extracts, but not purified protein is not surprising as prior studies with CFEs of E. coli showed the isomerization of menthone, and isomenthone that is likely to proceed via a classical glutamate racemase-type mechanism. 56 Therefore, subsequent preparative-scale biotransformation reactions were performed with 5 mM of (-)-menthone to both optimize menthide yield and purity. Figure S12 ). However, PDC polymers require the 'normal lactone' dihydrocarvide monomer, so the regio-selectivity of CHMO Phi1 needed to be altered to enable the desired product to be formed.
Prior mutagenesis studies of CHMO Ar and CHMO Ac showed that a substrate regio-selectivity change could be achieved by mutating three active site amino acids (F299A/F330A/F485A; CHMO Ar numbering). 54, 57 Homologous mutations in both enzymes led to a complete switch from producing the 'abnormal' to 'normal' lactone from (+)-dihydrocarvone. 54 An amino acid sequence alignment of CHMO Phi1 with CHMO Ar and CHMO Ac showed moderate homology (55%; results not shown), enabling the 3 targeted phenylalanine residues to be identified (F249, F280 and F435). The homologous variant (F249A, F280A and F435A) was generated for both CHMO Phi1 and CRE-CHMO Phi1 . The variant was expressed, purified (UV/Vis spectroscopy; Figures S1-S2; Table S2) and tested for activity with (+)-dihydrocarvone.
Biotransformations of variant CHMO Phi1 (both purified protein and CFEs) showed that the regioselectivity of the enzyme had successfully switched to forming the 'normal' lactone dihydrocarvide as the major product ( Figure S9b , S10b). Product identification was confirmed by 1 H and 13 C NMR using lactone purified from larger scale reactions ( Figure S13 ). (+)-dihydrocarvone is commercially available as a mixture of two isomers, the n-isomer (2R,5R) and the iso-isomer (2R,5S) at around 77:20 ratio ( Figure S8a ). Interestingly, reactions of purified WT and variant CHMO Phi1 with the commercially available (+)-dihydrocarvone showed conversion of only the (2R,5R)-isomer (>99%; Figure S9a , S9b), yet both isomers appeared to be consumed in reactions containing CFEs (>99%, Figure S10 ). This is likely due to the activity of a native E. coli enzyme capable of reacting with the (2R,5S) isomer of (+)-dihydrocarvone.
Preparative-scale lactone production. Larger-scale reactions (2 x 500 mL; 5 mM substrate) were performed to generate both menthide and dihydrocarvide using CFEs of CRE-CPDMO and the CRE-CHMO Phil1 variant, respectively. Each product was solvent extracted and purified to generate lactone oils (> 99% purity) with yields of 403 mg of menthide (47%) and 211 mg of dihydrocarvide (33%). The identity and purity of the lactones were confirmed by 1 H and 13 C NMR analysis ( Figure   S11 and S13).
As further proof of principle, the same methodology was applied to generate the lactone of (+)pulegone ((R)-4-methyl-7-(propan-2-ylidene)oxepan-2-one), Scheme 2 and the abnormal lactone of (+)-dihydrocarvone, Scheme 1B using CRE-CPDMO and WT CHMO Phil1 , respectively (Supporting Information for more details and NMR data). The products were purified (> 99%) and the structures confirmed by 1 H and 13 C NMR analysis ( Figure S12 and S14). The yield of lactone of (+)-pulegone and the abnormal lactone of (+)-dihydrocarvone were 121.4 mg (29.4%) and 190.1 mg (14.4%), respectively. Optimization to improve both the product yield and recovery after purification would be needed to increase the applicability of biosynthetic lactone production on an industrial scale.
Ring opening polymerization of lactone monomers.
We have demonstrated the efficient biosynthesis of a range of monoterpenoid lactone monomers on a preparative scale. The next stage is to implement a more environmentally friendly ROP to further improve the production of existing and novel bio-based polymers. By controlling the molecular weight and composition of the polymers, their properties can be tailored for use in diverse applications. 58 The BVMO-derived lactones menthide, dihydrocarvide and pulegone lactone were subjected to ROP reactions using [Mg(BHT) 2 (THF) 2 ] catalyst. 30 As a control, we also performed comparative ROP with commercially available ε-caprolactone, to enable a comparison of polymer sizes with previously published values. Each polymer was purified, and analysed by both 1 H NMR spectroscopy (Figure S15-S16) and triple detection GPC ( Figure S17 -S18), to confirm the polymeric nature and molecular distribution of the products (Table 3 ). There was no evidence of polymer formation with the pulegone lactone (see Supporting Information for discussion). In each case, the NMR spectra of the derived polymers was consistent with previously published spectra for PM, PDC and PCL. 19, 20, 30, 59, 60 The molecular mass and dispersity of purified PM (Table 3 ) was shown to be very similar to the previously described polymer generated using the same ROP catalyst with chemically-synthesised menthide (M w ~ 8.0 kD; Đ M ~ 1.2). 30 Therefore, the ROP polymerization of the bio-sourced menthide has successfully generated polymers of similar characteristics as PM from chemically synthesised monomers.
Polymers of bio-derived dihydrocarvide showed a very similar molecular mass and dispersity as PM ( Table 3 ). The only report of ROP using [Mg(BHT) 2 (THF) 2 ] catalyst with dihydrocarvide was co-polymerizations with ω-pentadecalactone. 30 Control PCL polymers showed similar number average molecular weight but broader dispersity (Đ M = 1.79) than PM and PDC ( The Mark-Houwink plot was generated for the three polymers ( Figure S25 structures excluding any formation of quaternary structure in solution and the observed dimeric arrangements are therefore crystallization artefacts.
The WT CHMO Phi1 structure shows the presence of a well-ordered control loop (residues 489-506), which is implicated in the catalytic mechanism of BVMO enzymes. 64 This suggests the enzyme is in a 'closed' conformation, as it closely resembles previously described CHMO tight 65 and CHMO closed structures. 66 In contrast, the control loop region of the variant CHMO Phi1 structure exhibits altered conformation and lack of electron density for residues 496-504. The altered residues (487-495) have significantly moved away from the active site, which resulted in the side chain of W493 now positioned at a distance of 6.4 Å (measured between NE atoms) from WT location. There is also a significant conformational change between the NADP + -binding domains of the two structures ( Figure 1B) . There are several notable active site differences between the WT and variant structures of CHMO Phi1 . In the WT closed structure, the nicotinamide ring of NADP + is positioned almost parallel to the isoalloxazine ring of FAD, with a distance of 2.81 Å between the N7 atom of NADP + and N5 of FAD. The conserved residues R330 and D60 form a salt bridge ( Figure 1C ), and are involved in the positioning of NADP + and substrate, as noted in prior work. 62 In the variant structure this interaction is absent, with one conformation of R330 positioned close to W493 (chain A, Figure 1D ) and the second between mutated residues A280 and A435 (chain B; Figure 1C -D).
Free from the salt bridge, D60 in the variant is pointing inwards into the active site. Detailed conformational studies of cyclohexanones show that the six-membered ring is likely to be most stable in a chair conformation, 71 with the two substituents placed in either an equatorial, equatorial (eq, eq), or in an axial, axial (ax, ax) arrangement (Scheme 2B). [72] [73] [74] [75] [76] [77] For CHMO Phi1catalysed (+)-dihydrocarvone oxidation, only the (2R, 5R) isomer is consumed. For this isomer, the equatorial conformation is slightly more favorable (by 1.8 kcal/mol -1 in the isolated (2R,5R) isomer at the present level of theory, in agreement with molecular mechanical studies of related cyclohexanone 75 . In the cluster models of the active site considered here ( Table 4 below), the energy preference (calculated by DFT) for the equatorial conformer increases in the reactant complex compared to the isolated substrate (by between 3.5 and 8.5 kcal mol -1 ), suggesting that the site is selective.
As the crystallographic data suggested significant differences in the active site on going from WT to variant structures of CHMO Phi1 , molecular dynamics (MD) simulations (see Supporting Information for details) were used to identify persistent steric interactions with the active site. Three independent replicas of molecular dynamics simulations were performed using the crystal structures of WT and variant CHMO Phi1 -NADPH-FAD without the substrate and the Criegee intermediate in both conformations. For the WT, this showed that the Criegee intermediate in the ax, ax conformation sterically clashes with nearby residues, making it less favorable than the eq, eq conformer. In contrast, both conformations are readily accommodated by the variant structure (see below and further discussion in Supporting Information for further discussion).
Simulations with the WT enzyme showed that the Criegee intermediate in the eq, eq conformation was stable during the 100 ns of MD simulation in three replicas, and interacted with residues F435, F249, F280 and W493 (Figure 2 The MD simulations suggest that close contacts with W493 destabilise the ax, ax conformer of the substrate, making the WT selective for the eq, eq conformer and leading to the abnormal product.
The mutations of F249A, F280A and F435A make the active site larger and, equally importantly, the control loop considerably more flexible. This suggests that both conformers, eq, eq and ax,ax, need to be considered to determine the balance between a kinetic preference for the normal lactone Table 4 ). The analyses did not model the Criegee intermediate formation because previous work found this to be energetically more accessible than the migration transition state for a cyclohexanone substrate. 78 Migration transition states for the regio-isomer of the lactone product in each case (where the migrating group is not antiperiplanar to the O-O peroxide bond) could not be accommodated in the cluster model, producing a range of close contacts that could not be relieved by optimisation within the geometry constraints used (chosen to reproduce the crystallographically-observed residue positions). The eq, eq conformer thus leads only to the abnormal lactone, whereas the ax, ax conformers gives only normal lactone. In contrast, optimization of the product complexes for both lactone products was successful. These active site models do not include any of the residues that were mutated to switch selectivity. Full structural analysis and breakdown of energies as well as a discussion of our approach can be found in the Supporting Information. As discussed above and in greater detail in the SI, residue W493 is important for interactions between the substrate and the residues in the active site, and was therefore included in M(med_W), which we consider a suitable model for the WT, with M(med) a possible model for the variant in which this residue moves away from the reacting site.
Active site models of the WT enzyme containing W493 (M(med_W)) show a clear preference for the eq, eq conformer of the substrate, with a lower barrier to reaction (18.8 vs 23.7 kcal moL -1 cf.
Criegee IM) compared to the ax, ax conformer. The substrate (eq, eq) moves closer to R330 to relieve close contacts with W493, and possibly also F249 and F435 (Figure 2A ). This model of the active site captures essential features of the WT enzyme.
In the absence of W493, as could occur in the variant, but retaining R330 in the model (M(med)), site selectivity is actually predicted to be enhanced for the reactant complexes, increasing the preference for the equatorial conformer to 8.5 kcal mol -1 . However, the MD simulations above and detailed structural analyses (see Supporting Information) suggest that interactions between the active site and the substrate or product are relatively weak and rely on hydrogen-bonding, making these calculation results noisy and more variable than for the Criegee intermediate in which the substrate is bound more strongly via O 2. This is discussed in detail in the Supporting Information.
We would encourage caution in over-interpretation of the reactant and product complex energies and their implications for selectivity. There is only a weak calculated preference for the Criegee intermediate of M(med) with respect to the equatorial conformer (near isoenergetic with ax, ax), with very similar transition state energies for the migration step (equatorial 17.9 kcal mol -1 vs. axial 19.3 kcal mol -1 vs. the related Criegee IMs). However, when barriers to migration compared to the same conformer's reactant complex are considered (considering the eq, eq and ax, ax only columns in Table 4 ), the axial conformer reacts via a lower barrier and the normal lactone product would be predicted to be produced in this case. This suggests the WT selectivity (modeled by M(med_W)) arises from a clear thermodynamic preference for the eq, eq conformer throughout, leading to the abnormal lactone, while the variant (modeled by M(med)) shows an erosion of the preference for the eq, eq conformer in the Criegee intermediate. At this stage, a switch to kinetic control may become possible, favoring the ax, ax conformer in the Criegee intermediate, which could then progress via a lower barrier to reach the migration transition state and produce the normal lactone.
The mutations were initially identified by Balke et al. 79 after docking of the normal lactone product of (2R,5R)-(+)-dihydrocarvone (ax, ax substrate conformer) into protein crystal structure geometries of the WT; in later work, a different lactone product, from the reaction of the (2S, 5S)-(+)dihydrocarvone enantiomer, was also considered. 57 These considerations led the authors to propose the sites for mutation, aimed at opening up the active site to better accommodate the normal lactone, with experimental evaluation used to select the final triple site mutation (F249A, F280A, F435A in the organism used here). As shown in Figure 2A for the relevant Criegee intermediates, these mutations do indeed give rise to a comparatively more open site. In addition, as discussed above, they increase the mobility of other residues, removing the W493 residue from close contacts in the reacting site. These changes could only be detected by MD simulation and crystallographic study of the variant CHMO Phi1 structure as reported here, and will probably reduce the number of unfavorable interactions with substrate conformers. By making the conformers more similar in energy to each other and so reducing inherent site selectivity, the kinetic preference for the O migrating to the more electron-rich 2-methyl substituent (axial conformer) becomes more important, producing the normal lactone. Such effects are subtle and require consideration of structures and reactivity. Quantifying the energy differences reliably would require extensive sampling (and calculations of binding affinities) rather than a cluster DFT or QM/MM calculation; as discussed in greater detail in the Supporting Information, this lies outside the scope of the present study.
This computational analysis demonstrates the importance of considering key stationary points along the reaction pathway during the computational screening and design process, as the site selectivity for substrate and product alone is not sufficient for explaining the observed product preferences.
The reactivity and selectivity changes are subtle, and several effects combine to give the observed outcome. Computational studies aimed at future design should carefully consider the whole range of potentially important and competing effects, of binding and reactivity. These computational models presented here should assist in prediction of selectivity for normal vs. abnormal lactone formation by natural and designed CHMOs. This should allow extension to other potential terpene substrates.
CONCLUSIONS
We present a semi-synthetic approach utilising biocatalysis with non-petroleum feedstocks as a practical route to potentially novel lactone monomers. This approach employs BVMO enzymes which provide control over the enantio-and regio-specificity of monomer production. Further, we have combined experimental and computational approaches to investigate and analyse the causes of the observed selectivity.
This interaction between structural biology, molecular dynamics simulations and quantum chemical models with experimental testing provides a guide for design and thus a roadmap for finding biocatalytic routes for the production of other monomers. We have also demonstrated that menthide and dihydrocarvide can be polymerized using a mild metal-organic catalyst. When combined with the control over isomers of the lactone monomers that biocatalysis enables, this opens up a broader range of polymer physical properties and behaviours for a wide range of applications.
Our platform technology to existing and novel lactone-based polymers combines biocatalyst identification (and potentially future design), adaptation to optimize regio-selective control of monomer formation and environmentally friendly polymer chemistry. Access to existing and novel monomers with improved performance and functionality from feedstocks has the potential to transform polymer production by providing routes to their manufacture, a key element of a nascent circular economy.
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